Bifurcation Lesions Market Growing Incidence of Coronary Artery Disease across the Globe

According to Precision Business Insights (PBI), the latest report, the bifurcation lesions market was valued at USD 2,257.5 million in 2022 and is expected to grow at a 5.3% CAGR during the forecast period 2023 to 2029. The primary drivers of the expansion of the global bifurcation lesions market include the increasing prevalence of coronary artery diseases across the globe. In addition, growing number of geriatric populations is expected to boost the growth of bifurcation lesions market over the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/bifurcation-lesions-market

Coronary Vascular Segment is expected to Dominate the Bifurcation Lesions Market:
Based on the application, the global bifurcation lesions market is segmented into coronary vascular and peripheral vascular. The coronary vascular segment is expected to account for a larger revenue share in the global bifurcation lesions market. Availability of dedicated products for coronary bifurcation lesions along with the increasing number of percutaneous coronary intervention procedures are expected to drive the growth of the bifurcation lesions market in this segment. In addition, growing awareness about the minimally invasive procedures for the treatment of bifurcation lesions, and ongoing clinical trials and investments by market players is expected to further propel the growth of bifurcation lesions market in this segment over the forecast period.

The bifurcation lesions market is segmented based on type, application, and geography.
Based on the type, the market is segmented into the following:
• One Stent
• Two Stent

Based on the application, the market is segmented into the following:
• Coronary Vascular
• Peripheral Vascular

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

North America Bifurcation Lesions Market:
The North America bifurcation lesions market is expected to increase over the forecast period due to the increasing incidence of coronary artery diseases in this region along with the growing geriatric population. For instance, according to the report of National Center of Health Statistics, the coronary artery disease is the cause for 1 in every 4 fatalities in United States and about 470,000 people are living with myocardial infraction in US. In addition, growing investment in research and development for the treatment of bifurcation lesions along with the increasing demand for drug eluting stents in this region is expected to boost the market growth. Furthermore, commercialization of devices for bifurcation lesions in this region is expected to have a positive impact on the growth of bifurcation lesions market.

Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=422004

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global Bifurcation Lesions market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region.

Key players profiles in the bifurcation lesions market report are Abbott, Boston Scientific Corporation, Cardinal Health, Medtronic, Johnson & Johnson private ltd, Tecomet, C. R. Bard, Inc, Philips Healthcare, Terumo Medical Corporation, Tryton Medical, Inc., Stryker.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.